 |
|
Blood pressure prior to percutaneous coronary intervention is associated with the risk of end-stage renal disease: a nationwide population based-cohort study
Eun Hui Bae, Sang Yup Lim, Bongseong Kim, Kyung-Do Han, Tae Ryom Oh, Hong Sang Choi, Chang Seong Kim, Seong Kwon Ma, Soo Wan Kim
Kidney Res Clin Pract. 2021;40(3):432-444. Published online 2021 Jul 2 DOI: https://doi.org/10.23876/j.krcp.21.245
|
|
Citations to this article as recorded by
 Blood pressure levels and risk of end-stage renal disease in patients with type 2 diabetes who underwent percutaneous coronary intervention: a nationwide population-based study
Hyunglae Kim, Yong-Moon Park, Seung-Hyun Ko, Yun-Jung Cho, Hyung Wook Kim, Yong Kyun Kim, Kyung-Do Han, Jae-Seung Yun, Kyuho Kim, Donggyu Moon
Scientific Reports.2025;[Epub] CrossRef Fenofibrate and risk of end‐stage renal disease: A nationwide cohort study
Young Youl Hyun, Kyung‐Soo Kim, Sangmo Hong, Kyungdo Han, Cheol‐Young Park
Diabetes, Obesity and Metabolism.2024; 26(10): 4583. CrossRef Obesity-related hypertension and chronic kidney disease: from evaluation to management
Mi-Hyang Jung, Sang-Hyun Ihm
Kidney Research and Clinical Practice.2023; 42(4): 431. CrossRef
|